LivaNova PLC - Ordinary Shares (LIVN)

LivaNova PLC (NASDAQ:LIVN): An Undervalued Opportunity in Medical Technology

When you look at LIVANOVA PLC (NASDAQ:LIVN), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

Discover LIVANOVA PLC, an undervalued stock. NASDAQ:LIVN showcases solid financial health and profitability while maintaining an appealing valuation.

LivaNova gets Buy rating from Goldman Sachs analyst. $65 PT. The company appears poised for consistent revenue growth in its base business.

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.

LIVN stock results show that LivaNova beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

LIVN stock results show that LivaNova beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term.

U.S. stocks traded mixed, with the Dow Jones gaining around 50 points on Wednesday. Here are some big stocks recording gains in today’s session.